John R. Schreiber

Affiliations: 
Case Western Reserve University School of Medicine, Cleveland, OH, United States 
Area:
Microbiology Biology, Immunology
Google:
"John Schreiber"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Schreiber JR. (2012) Role of Toll like receptors in the antibody response to encapsulated bacteria. Frontiers in Bioscience (Elite Edition). 4: 2638-46
Taylor CE, Cobb BA, Rittenhouse-Olson K, et al. (2012) Carbohydrate moieties as vaccine candidates: targeting the sweet spot in the immune response. Vaccine. 30: 4409-13
Greenspan NS, Lu MA, Shipley JW, et al. (2012) IgG3 deficiency extends lifespan and attenuates progression of glomerulonephritis in MRL/lpr mice. Biology Direct. 7: 3
Lai Z, Schreiber JR. (2011) Outer membrane protein complex of Meningococcus enhances the antipolysaccharide antibody response to pneumococcal polysaccharide-CRM₁₉₇ conjugate vaccine. Clinical and Vaccine Immunology : Cvi. 18: 724-9
Lucas AH, Rittenhouse-Olson K, Kronenberg M, et al. (2010) Carbohydrate Moieties as Vaccine Candidates: meeting summary. Vaccine. 28: 1121-31
Lai Z, Schreiber JR. (2009) Antigen processing of glycoconjugate vaccines; the polysaccharide portion of the pneumococcal CRM(197) conjugate vaccine co-localizes with MHC II on the antigen processing cell surface. Vaccine. 27: 3137-44
Kaur K, Chowdhury S, Greenspan NS, et al. (2007) Decreased expression of tumor necrosis factor family receptors involved in humoral immune responses in preterm neonates. Blood. 110: 2948-54
McLean MD, Almquist KC, Niu Y, et al. (2007) A human anti-Pseudomonas aeruginosa serotype O6ad immunoglobulin G1 expressed in transgenic tobacco is capable of recruiting immune system effector function in vitro. Antimicrobial Agents and Chemotherapy. 51: 3322-8
John CC, Schreiber JR. (2006) Therapies and vaccines for emerging bacterial infections: learning from methicillin-resistant Staphylococcus aureus. Pediatric Clinics of North America. 53: 699-713
Lai Z, Kimmel R, Petersen S, et al. (2005) Multi-valent human monoclonal antibody preparation against Pseudomonas aeruginosa derived from transgenic mice containing human immunoglobulin loci is protective against fatal pseudomonas sepsis caused by multiple serotypes. Vaccine. 23: 3264-71
See more...